Purine Nucleosides and Analogues Bearing Chiral Substituents: Medicinal Chemistry and Therapeutic Perspective
- 作者: Drenichev M.1, Borokh V.1
-
隶属关系:
- Laboratory of Design and Synthesis of Biologically Active Compounds, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
- 期: 卷 31, 编号 6 (2024)
- 页面: 671-682
- 栏目: Anti-Infectives and Infectious Diseases
- URL: https://permmedjournal.ru/0929-8673/article/view/645171
- DOI: https://doi.org/10.2174/0929867330666230420152130
- ID: 645171
如何引用文章
全文:
详细
Adenosine and its analogues play an important role as bioregulators of metabolic processes in animal cells, affecting a variety of metabolic functions by acting through the purinergic signaling system. Synthesis and structure-activity relationship for some known purine nucleosides bearing chiral substituents are considered in this work. These compounds represent a promising potential as drug prototypes for targeted therapy of cancer, metabolic dysfunctions, and neuronal disorders due to their enhanced selectivity to receptors of the purinergic signaling system. Derivatives of adenosine and guanosine containing a chiral substituent also manifest antiviral activity.
作者简介
Mikhail Drenichev
Laboratory of Design and Synthesis of Biologically Active Compounds, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
编辑信件的主要联系方式.
Email: info@benthamscience.net
Valentina Borokh
Laboratory of Design and Synthesis of Biologically Active Compounds, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Email: info@benthamscience.net
补充文件
